Elsewhere Online twitter Facebook SLS Blogs YouTube SLS Channel Linked In SLSNavigator SLS on Flickr

CLB Speaker Series: Gregg Alton, Gilead on International Drug Access and IP


February 1, 2010 5:00pm - 6:00pm

Room 280B


    Gregg Alton, Executive VP of Gilead

    Gilead’s International Access Program: Drug Access and IP

    Monday, February 1, 5 - 6 p.m.
    Room 280B , Stanford Law School – Food will be served

    Gregg Alton is the Executive Vice President of Gilead, and formerly General Counsel. In his current role, Mr. Alton is responsible for legal affairs, government affairs, medical affairs, public affairs, and international access activities. He will discuss Gilead's international access program, which promotes access to Gilead therapeutics for HIV/AIDS and leishmaniasis treatment in the developing world. Mr. Alton will discuss IP issues involved, including licensing with Indian generic manufacturers, and the future and sustainability of the model. Dinner will be served.

    Related Media